PREVIEW
Although opportunistic infections are becoming less prevalent since the advent of highly active antiretroviral therapies for AIDS, they remain a significant threat to immunocompromised patients. The options for prevention and treatment of AIDS-related infections are increasing as research into new drugs and more effective combination regimens continues. In this comprehensive article, Dr Cavert looks at the chief opportunistic infections still plaguing patients with HIV infection and highlights recent changes in prophylaxis and treatment recommendations.